argenx SE (ARGX)
NASDAQ: ARGX · Real-Time Price · USD
788.49
-7.08 (-0.89%)
At close: Jan 9, 2026, 4:00 PM EST
790.00
+1.51 (0.19%)
After-hours: Jan 9, 2026, 5:42 PM EST
argenx SE Market Cap
argenx SE has a market cap or net worth of $49.38 billion as of January 9, 2026. Its market cap has increased by 32.37% in one year.
Market Cap
49.38B
Enterprise Value
45.52B
1-Year Change
32.37%
Ranking
Category
Stock Price
$788.49
Market Cap Chart
Since May 18, 2017, argenx SE's market cap has increased from $618.00M to $49.38B, an increase of 7,889.59%. That is a compound annual growth rate of 65.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 8, 2026 | 48.56B | -5.40% |
| Dec 31, 2025 | 51.33B | 39.57% |
| Dec 31, 2024 | 36.77B | 72.75% |
| Dec 29, 2023 | 21.29B | 2.05% |
| Dec 30, 2022 | 20.86B | 15.89% |
| Dec 31, 2021 | 18.00B | 29.92% |
| Dec 31, 2020 | 13.85B | 126.49% |
| Dec 31, 2019 | 6.12B | 96.21% |
| Dec 31, 2018 | 3.12B | 83.75% |
| Dec 29, 2017 | 1.70B | 174.53% |
| May 18, 2017 | 618.00M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 952.29B |
| Johnson & Johnson | 492.44B |
| AbbVie | 388.97B |
| UnitedHealth Group | 311.59B |
| AstraZeneca | 295.57B |
| Merck & Co. | 274.34B |
| Novartis AG | 272.98B |
| Novo Nordisk | 263.81B |